A citation-based method for searching scientific literature

Yoshiaki Kinoshita, Kentaro Watanabe, Hiroshi Ishii, Hisako Kushima, Masaki Fujita, Kazuki Nabeshima. Histopathology 2017
Times Cited: 21



Yasunori Enomoto, Yutaro Nakamura, Yasuomi Satake, Hiromitsu Sumikawa, Takeshi Johkoh, Thomas V Colby, Hideki Yasui, Hironao Hozumi, Masato Karayama, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Naoki Inui, Toshihide Iwashita, Shigeki Kuroishi, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Takashi Yamada, Toshihiro Shirai, Hiroshi Hayakawa, Takafumi Suda. Respir Med 2017
Times Cited: 58




List of shared articles



Times cited

Platythorax progresses with lung involvement in pleuroparenchymal fibroelastosis.
Takato Ikeda, Yoshiaki Kinoshita, Takuto Miyamura, Yusuke Ueda, Yuji Yoshida, Hisako Kushima, Hiroshi Ishii. Respir Investig 2022
0

The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.
Hiroshi Ishii, Yoshiaki Kinoshita, Hisako Kushima, Nobuhiko Nagata, Kentaro Watanabe. Chron Respir Dis 2019
7

Role of alveolar collapse in idiopathic pleuroparenchymal fibroelastosis.
Yoshiaki Kinoshita, Hiroshi Ishii, Hisako Kushima, Masaki Fujita, Kazuki Nabeshima, Kentaro Watanabe. Sarcoidosis Vasc Diffuse Lung Dis 2020
3

The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.
Yoshiaki Kinoshita, Hiroshi Ishii, Kazuki Nabeshima, Kentato Watanabe. Histol Histopathol 2021
4

Podoplanin-positive myofibroblasts: a pathological hallmark of pleuroparenchymal fibroelastosis.
Yasunori Enomoto, Sayomi Matsushima, Shiori Meguro, Hideya Kawasaki, Isao Kosugi, Tomoyuki Fujisawa, Noriyuki Enomoto, Naoki Inui, Yutaro Nakamura, Takafumi Suda,[...]. Histopathology 2018
7

Remodeling of the pulmonary artery in idiopathic pleuroparenchymal fibroelastosis.
Yoshiaki Kinoshita, Hiroshi Ishii, Hisako Kushima, Takeshi Johkoh, Hidetake Yabuuchi, Masaki Fujita, Kazuki Nabeshima, Kentaro Watanabe. Sci Rep 2020
5

Physiological Criteria Are Useful for the Diagnosis of Idiopathic Pleuroparenchymal Fibroelastosis.
Takato Ikeda, Yoshiaki Kinoshita, Yusuke Ueda, Tomoya Sasaki, Hisako Kushima, Hiroshi Ishii. J Clin Med 2020
5

A proposed prognostic prediction score for pleuroparenchymal fibroelastosis.
Yoshiaki Kinoshita, Takato Ikeda, Takuto Miyamura, Yusuke Ueda, Yuji Yoshida, Hisako Kushima, Masaki Fujita, Takashi Ogura, Kentaro Watanabe, Hiroshi Ishii. Respir Res 2021
2

Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.
Kentaro Watanabe, Hiroshi Ishii, Fumiaki Kiyomi, Yasuhiro Terasaki, Akira Hebisawa, Yoshinori Kawabata, Takeshi Johkoh, Fumikazu Sakai, Yasuhiro Kondoh, Yoshikazu Inoue,[...]. Respir Investig 2019
34

Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.
Felix Chua, Sujal R Desai, Andrew G Nicholson, Anand Devaraj, Elisabetta Renzoni, Alexandra Rice, Athol U Wells. Ann Am Thorac Soc 2019
44

Serum latent transforming growth factor-β binding protein 4 as a novel biomarker for idiopathic pleuroparenchymal fibroelastosis.
Yoshiaki Kinoshita, Takato Ikeda, Hisako Kushima, Masaki Fujita, Tomoyuki Nakamura, Kazuki Nabeshima, Hiroshi Ishii. Respir Med 2020
3

Limited efficacy of nintedanib for idiopathic pleuroparenchymal fibroelastosis.
Yoshiaki Kinoshita, Takuto Miyamura, Takato Ikeda, Yusuke Ueda, Yuji Yoshida, Hisako Kushima, Hiroshi Ishii. Respir Investig 2022
0

Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases.
Yoshiaki Kinoshita, Kentaro Watanabe, Hiroshi Ishii, Hisako Kushima, Makoto Hamasaki, Masaki Fujita, Kazuki Nabeshima. Virchows Arch 2019
13